Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting to Present at the H.C. Wainwright BioConnect Conference

CORALVILLE, IA / ACCESSWIRE / January 5, 2022 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle oncology

Related Keywords

Jenene Thomas ,Kostenloser Wertpapierhandel ,Francesl Johnson ,Hc Wainwright Bioconnect ,Viewpoint Molecular Targeting Inc ,Company Melanoma ,Viewpoint Molecular Targeting ,Chief Executive Officer ,Bioconnect Conference ,Molecular Targeting ,Neuroendocrine Tumor ,Investor Inquiries ,Viewpoint ,Olecular ,Targeting ,Present ,Wainwright ,Bioconnect ,Conference ,